AI-Powered News AnalysisCompare coverage across the political spectrum

#dr reddy's

Related Pages (6)

Untitled

window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa

news.google.comJuly 23, 2026

Untitled

window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa

news.google.comJuly 23, 2026

Untitled

window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa

news.google.comJuly 9, 2026

Dr Reddy's files 'Obeda' trademark ahead of generic ozempic launch

Hyderabad-based Dr Reddy’s Laboratories has applied to trademark the brand name and logo “Obeda”, according to sources. The proposed brand is expected to be the company’s version of semaglutide, the

indiatoday.inFebruary 26, 2026

Dr Reddy's gearing up for March debut of generic semaglutide Obeda, sources say

Listen to this article in summarized format Unlock AI Briefing and Premium Content (Catch all the Business News, Breaking News and Latest News Updates on The Economic Times.) Subscribe to The Econo

economictimes.indiatimes.comFebruary 26, 2026

Untitled

window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa

news.google.comFebruary 26, 2026